← Open Payments lookup

CATHERINE HARRINGTON: Open Payments

NPI 1962445627 · MAX MEADOWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491 in 30 payments from 12 companies in 2025. Trend: 2023 $405 · 2024 $582 · 2025 $491

Food & beverage: $491
CompanyPaymentsAmount
ABBVIE INC.13$165
Vanda Pharmaceuticals Inc.3$52
Amgen Inc.3$46
AstraZeneca Pharmaceuticals LP2$45
PFIZER INC.2$39
Dexcom, Inc.1$26
Otsuka America Pharmaceutical, Inc.1$25
Novo Nordisk Inc1$25
Lilly USA, LLC1$21
Axsome Therapeutics, Inc.1$19

Products named: VRAYLAR, QULIPTA, OTEZLA, FANAPT, AIRSUPRA, Dexcom G6 Transmitter, REXULTI, Ozempic.

Industry payments across VA — which companies pay providers there.